Skip to main content

Advertisement

Log in

Elevated levels of soluble fibrin in patients with venous thromboembolism

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The fibrin-related markers (FRMs), including soluble fibrin (SF), d-dimer and fibrin and fibrinogen degradation products (FDP) are considered to be useful for the diagnosis of thrombosis; however, evidence for the diagnosis of thrombosis by SF is still not well established. The present study was designed to evaluate the usefulness of SF in the diagnosis of venous thromboembolism (VTE). The plasma concentrations of FRMs were measured in 551 in-patients suspected to have a VTE. The plasma levels of SF, d-dimer and FDP were significantly higher in patients with VTE than patients without VTE and those were significantly higher in patients without VTE than in healthy volunteers. In a receiver operating characteristic analysis for the diagnosis of VTE, the area under the curve was 0.950 for SF, 0.933 for FDP and 0.805 for d-dimer. The appropriate cut-off values for the diagnosis were as follows SF 5.9 μg/ml, FDP 2.1 μg/ml and d-dimer 4.8 μg/ml. To obtain a 100% negative predictive value for the diagnosis of VTE, the SF was less than 5.2 μg/ml, FDP was less than 1.3 μg/ml, and d-dimer was less than 0.5 μg/ml. Our findings suggest that the SF assay is useful for the diagnosis and exclusion of VTE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wada H, Sakuragawa N. Are fibrin-related markers useful for the diagnosis of thrombosis? Semin Thromb Hemost. 2008;34:33–8. doi:10.1055/s-2008-1066021.

    Article  CAS  PubMed  Google Scholar 

  2. Wada H, Kobayashi T, Abe Y, Hatada T, Yamada N, Sudo A, et al. Elevated levels of soluble fibrin or d-dimer indicate high risk of thrombosis. J Thromb Haemost. 2006;4:1253–8. doi:10.1111/j.1538-7836.2006.01942.x.

    Article  CAS  PubMed  Google Scholar 

  3. Linkins LA, Bates SM, Ginsberg JS, Kearon C. Use of different d-dimer levels to exclude venous thromboembolism depending on clinical pretest probability. J Thromb Haemost. 2004;2:1256–60. doi:10.1111/j.1538-7836.2004.00824.x.

    Article  CAS  PubMed  Google Scholar 

  4. Le Gal G, Bounameaux H. Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients. J Thromb Haemost. 2004;2:1244–6. doi:10.1111/j.1538-7836.2004.00795.x.

    Article  CAS  PubMed  Google Scholar 

  5. Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004;2:1247–55. doi:10.1111/j.1538-7836.2004.00790.x.

    Article  CAS  PubMed  Google Scholar 

  6. Wada H, Sakuragawa N, Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost. 1998;24:293–7.

    Article  CAS  PubMed  Google Scholar 

  7. Lehman CM, Wilson LW, Rodgers GM. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric d-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol. 2004;122:178–84. doi:10.1309/X4YN001GU51NGG9Y.

    Article  PubMed  Google Scholar 

  8. Wada H, Sase T, Matsumoto T, Kushiya F, Sakakura M, Mori Y, et al. Increased soluble fibrin in plasma from disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2003;9:233–40. doi:10.1177/107602960300900308.

    Article  CAS  PubMed  Google Scholar 

  9. Tanigawa M, Wada H, Minamikawa K, Wakita Y, Nagaya S, Mori T, et al. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Am J Hematol. 1995;49:1–5. doi:10.1002/ajh.2830490102.

    Article  CAS  PubMed  Google Scholar 

  10. Saito Y, Wada H, Yamamuro M, Inouue A, Shimura M, Hiyoyama K, et al. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease. Am J Hematol. 1999;61:238–42. doi:10.1002/(SICI)1096-8652(199908)61:4<238::AID-AJH3>3.0.CO;2-8.

    Article  CAS  PubMed  Google Scholar 

  11. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, Minami N, Deguchi K, Suzuki K, Nakano T, Shirakawa S. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Am J Hematol. 1993;44:101–5. doi:10.1002/ajh.2830440206.

    Article  CAS  PubMed  Google Scholar 

  12. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–30.

    CAS  PubMed  Google Scholar 

  13. Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O’Fallon WM, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86:452–63.

    CAS  PubMed  Google Scholar 

  14. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000;83:657–60.

    CAS  PubMed  Google Scholar 

  15. Courtney DM, Kline JA. Identification of prearrest clinical factors associated with outpatient fatal pulmonary embolism. Acad Emerg Med. 2001;8:1136–42. doi:10.1111/j.1553-2712.2001.tb01129.x.

    Article  CAS  PubMed  Google Scholar 

  16. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, et al. Evaluation of d-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349:1227–35. doi:10.1056/NEJMoa023153.

    Article  CAS  PubMed  Google Scholar 

  17. Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. N Engl J Med. 2003;349:1247–55. doi:10.1056/NEJMcp035442.

    Article  PubMed  Google Scholar 

  18. Nieuwenhuizen W. A reference material for harmonization of d-dimer assays. Thromb Haemost. 1997;77:1031–3.

    CAS  PubMed  Google Scholar 

  19. Dempfle CE, Zips S, Ergül H, Heene DL. The FACT study group: the fibrin assay comparison trial (FACT). Thromb Haemost. 2001;85:671–8.

    CAS  PubMed  Google Scholar 

  20. Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Helots. 2001;27:657–66. doi:10.1055/s-2001-18870.

    Article  CAS  Google Scholar 

  21. Van der Putten RF, Glatz JF, Hermens WT. Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta. 2006;371:37–54. doi:10.1016/j.cca.2006.03.005.

    Article  PubMed  Google Scholar 

  22. Brass EP, Forman WB, Edwards RV, Lindan O. Fibrin formation; the role of fibrinogen-fibrin monomer complex. Thromb Haemost. 1976;36:37–48.

    CAS  PubMed  Google Scholar 

  23. Graeff H, Hafter R, von Hugo R. On soluble fibrinogen-fibrin complexes. Thromb Res. 1979;16:575–6. doi:10.1016/0049-3848(79)90106-3.

    Article  CAS  PubMed  Google Scholar 

  24. Soe G, Kohno I, Inuzuka K, Itoh Y, Matsuda M. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: Its application to the measurement of soluble fibrin in plasma. Blood. 1996;88:2109–17.

    CAS  PubMed  Google Scholar 

  25. Suzuki A, Ebinuma H, Matsuo M, Miyazaki O, Yago H. The monoclonal antibody that recognize an epitope in the C-terminal region of the fibrinogen α-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products. Thromb Res. 2007;121:377–85. doi:10.1016/j.thromres.2007.05.008.

    Article  CAS  PubMed  Google Scholar 

  26. Goldstein BJ, Mushlin AI. Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med. 1987;2:20–4. doi:10.1007/BF02596245.

    Article  CAS  PubMed  Google Scholar 

  27. Hamano A, Tanaka S, Takeda Y, Umeda M, Sakata Y. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma. Clin Chim Acta. 2002;318:25–32. doi:10.1016/S0009-8981(01)00779-3.

    Article  CAS  PubMed  Google Scholar 

  28. Nomura H, Wada H, Mizuno T, Katayama N, Abe Y, Noda M, et al. Negative predictive value of d-dimer for diagnosis of venous thromboembolism. Int J Hematol. 2008;87:250–5. Epub ahead of print.

    Article  CAS  PubMed  Google Scholar 

  29. Ota S, Wada H, Nobori T, Kobayashi T, Nishio M, Nishioka Y, et al. Diagnosis of deep vein thrombosis by plasma-soluble fibrin or d-dimer. Am J Hematol. 2005;79:274–80. doi:10.1002/ajh.20396.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by research grants from the Japanese Ministry of Health, Labour and Welfare, from the Japanese Ministry of Education, Science, Sports and Culture and the Mie University COE Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideo Wada.

About this article

Cite this article

Tsuji, A., Wada, H., Matsumoto, T. et al. Elevated levels of soluble fibrin in patients with venous thromboembolism. Int J Hematol 88, 448–453 (2008). https://doi.org/10.1007/s12185-008-0173-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-008-0173-5

Keywords

Navigation